Pneumococcal infections in HIV-infected adults

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Bacterial pneumonia, particularly pneumococcal infection, is a leading cause of illness and death in individuals with human immunodeficiency virus (HIV).
• HIV infection can directly cause illness and potentially accelerate HIV progression.
• While clinical presentation and treatment response often mirror those in non-HIV infected patients, radiographic findings may differ.

Observation:

• HIV-infected patients face a higher risk of invasive pneumococcal disease, extrapulmonary infections, and increased mortality.
• HIV compromises the immune system's ability to combat Streptococcus pneumoniae, leading to prolonged colonization.
• The clinical significance of increasing drug-resistant pneumococcal strains remains unclear.

Findings:

• The 23-valent pneumococcal vaccine covers at least 90% of strains causing invasive pneumococcal disease.
• Vaccine response diminishes with increasing immunodeficiency, but benefits for responders are substantial with minimal risk.

Implications:

• The 23-valent pneumococcal vaccine is advised for all individuals with HIV.
• Vaccination strategies are crucial for mitigating pneumococcal disease burden in the HIV-infected population.